Skip to main content
. 2018 Mar 24;20(9):1215–1224. doi: 10.1093/neuonc/noy047

Table 3.

Survival

N (%)
Surveys
 KPS 12 (71)
 ECOG 8 (47)
 Tokuhashi 3 (18)
 Tomita 3 (18)
 Bauer 1 (6)
Ongoing Clinical Trials
 ECOG/Zubrod 15 (48)
 KPS 11 (35)